Document is current
Any future updates will be listed below
-
Authors
Cai, Mei-Na
Chen, Dong-Mei
Chen, Xin-Ru
Gu, Yu-Rong
Liao, Chun-Hong
Xiao, Le-Xin
Wang, Jia-Liang
Lin, Bing-Liang
Huang, Yue-Hua
Lian, Yi-Fan
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81902397, 82070612, 81902397, 82070612)
Guangzhou Science and Technology Program Key (2023B03J0154, 2023B01J1007)
Research and Development Planned Project in Key Areas of Guangdong Province (2019B110233002, 2019B110233002)
General Planned Project of Guangzhou Science and Technology (202201010950, 202201020422)
- License Information
-
More Information
Article History
Accepted: 11 July 2024
First Online: 30 July 2024
Declarations
:
: The study was approved by the Institute Research Ethics Committee at the Third Affiliated Hospital of Sun Yat-sen University. Written informed consent was obtained from each patient. (1) Title of the approved project: COLEC10 inhibiting hepatocellular carcinoma by suppressing β-catenin pathway; (2) Approval number: A2023-423-01; (3) Date of approval: 19/06/2023.
: The authors declare no competing interests.
